Study of LMN-401 in people with an ileostomy
Part of Digestive system, Infections clinical trials.
This study looks at how your body absorbs the drug LMN-401 when you have an ileostomy. It's designed to understand the effect of your digestive system on the medicine.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 19 years or older.
- Your overall health should be stable.
- You must have a mature ileostomy that hasn't been changed or revised in the last 6 months.
- You must be willing to attend all study visits.
- You cannot be using anti-diarrhea medication or opioids.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new investigational drug (called LMT503) for the first time in humans, in healthy volunteers. It is a phase 1 trial that will look at how the body processes the drug and its safety, including how it behaves in the blood. The trial involves taking the drug once (single dose) or multiple times over several days, with close monitoring by the research team.
This study looks at how plant chemicals (called polyphenols) are absorbed in people with an ileostomy. It aims to understand digestion and could help guide future nutrition advice for ileostomy patients.
This trial looks at how well your body absorbs certain medications if you have an ileostomy or colostomy. It aims to help doctors better understand dosing for people with ostomies.
This study tests an investigational drug called LIV001 for people with mild-to-moderate ulcerative colitis. It aims to see if the drug is safe and may help reduce inflammation in the colon.
This trial tests a new medicine called LYNC-101 in healthy volunteers to see if it is safe and how the body processes it. If you are a generally healthy adult between 18 and 60, you may be able to help researchers learn about this potential treatment.
This trial tests a new medicine called IN-114199 in healthy people to see if it is safe and how the body handles it. It is a first-in-human study, meaning it is the first time this drug is given to people.
Hear when a new Travelers Diarrhea trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.